
The FDA has approved a second round of the Moderna Inc (NASDAQ: MRNA) or Pfizer Inc (NYSE:PFE), and BioNTech SE (NASDAQ:BNTX) COVID-19 vaccines for older people and certain immunocompromised individuals.
The agency said the new boosters would be administered at least four months after the previous dose.